1
And. 2UKK Institute for Health Promotion Research and National Institute for Health and Welfare (THL), P.O. Box 3033501, Tampere, Finland. 3 Department of Epidemiology and Biostatistics, National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia. Received: 15 February 2012 Accepted: 17 December 2012 Published: 21 December 2012 References 1. Hemminki E, Topo P, Kangas I: Experience
1
E not available for all women. Furthermore the numbers of women in early menopause were few. These complications of data led us to the crude analysis used in the study. However, our analysis was good enough to show the variability between women, and suggest the need for larger follow-up studies to describe the natural course of menopausal symptoms. To estimate the duration of symptoms among unsele
1
And. 2UKK Institute for Health Promotion Research and National Institute for Health and Welfare (THL), P.O. Box 3033501, Tampere, Finland. 3 Department of Epidemiology and Biostatistics, National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia. Received: 15 February 2012 Accepted: 17 December 2012 Published: 21 December 2012 References 1. Hemminki E, Topo P, Kangas I: Experience
1
Unmilola OM, Taiwo LO: Experience of menopausal symptoms by women in an urban community in Ibadan, Nigeria. Menopause 2008, 16:1?. 5. R str K, Bengtsson C, Lissner L, Milsom I, Sundh V, Bj kelund C: A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002, 9:156?61. 6. National Institutes of Health state of sci
1
Ps were very similar by the studied background characteristics. Table 2 gives the prevalence of vasomotor symptoms according to a cross-sectional analysis. At the time of recruitment, about two thirds of the women reported vasomotor symptoms, and about a half regarded them as bothersome. In the survey a year later, less (53 ) of women reported vasomotor symptoms and a third found them bothersome.
1
And. 2UKK Institute for Health Promotion Research and National Institute for Health and Welfare (THL), P.O. Box 3033501, Tampere, Finland. 3 Department of Epidemiology and Biostatistics, National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia. Received: 15 February 2012 Accepted: 17 December 2012 Published: 21 December 2012 References 1. Hemminki E, Topo P, Kangas I: Experience
1
Uscript. RL commented the manuscript. PV participated in the designing of the analysis and commented the manuscript. All authors read and approved the final manuscript. Acknowledgement This study was partly financed by Academy of Finland grant 2007?010 (decision number 115088). We thank all women who participated in the trial, the trial staff at clinical centres, and the staff at the National Inst
1
And. 2UKK Institute for Health Promotion Research and National Institute for Health and Welfare (THL), P.O. Box 3033501, Tampere, Finland. 3 Department of Epidemiology and Biostatistics, National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia. Received: 15 February 2012 Accepted: 17 December 2012 Published: 21 December 2012 References 1. Hemminki E, Topo P, Kangas I: Experience